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 Introduction 
Breast and cervical cancer are the leading cause of cancer morbidity and mortality in women. 
In Sub-Saharan Africa (SSA) breast cancer is the most commonly diagnosed cancer among 
women, whilst cervical cancer remains the leading cause of cancer death.1 Yet, if diagnosed 
early, both cancers are treatable with curative intent.  Worldwide, most cancers (85-90%) are 
diagnosed following symptomatic presentation.2  Consequently, understanding processes 
related to cancer symptom epidemiology, symptom awareness and responses to symptoms are 
important in developing interventions to promote timely cancer diagnosis. For both breast 
and cervical cancer, women often fail to recognise or misinterpret these symptoms or wait 
until symptoms (and disease) progress before they seek medical attention.3,4 For example, 
patients in Nepal have been shown to be more likely to recognise vaginal bleeding and seek 
care for symptoms, in contrast to recognising foul smelling vaginal discharge.5 For breast 
cancer, women are more likely to recognise and seek care for breast lumps in contrast to non-
lump symptoms.6  There is evidence that interventions to increase awareness lead to better 
outcomes.7 For instance, a Malaysian study reported earlier help-seeking for breast and 
cervical cancers following an intervention targeted at raising public awareness of symptoms  
Background: In Sub-Saharan Africa (SSA) breast cancer is the most commonly diagnosed cancer 
among women, whilst cervical cancer remains the leading cause of cancer death. Women often fail 
to recognise or misinterpret possible symptoms, so breast and cervical cancer symptom awareness 
information can promote timely help-seeking behaviour, diagnosis and start of treatment. 
 
Aim: To identify tools which have been utilised to measure breast and cervical cancer symptom 
awareness in SSA.   
 
Methods: A scoping review of articles published between January 1997 and February 2017, 
written in English, and describing primary research in breast and/or cervical cancer symptom 
awareness-related topics in SSA contexts, was undertaken across five databases.  The approach 
was supported by Colquhoun et al’s methodological framework for scoping reviews. 
 
Results: 41 studies were included from 11 SSA countries. Almost half (20/41) used breast and/or 
cervical cancer symptom awareness tools but did not report on tool validation processes.  The rest 
(21/41) made reference to some tool validation, yet only two reported a detailed account of their 
tool validation processes. One explored lay perceptions of breast cancer, while the other sought to 
establish the validity and reliability of a UK tool in a Kenyan context. 
 
Conclusion: The findings point to the dearth of comprehensively validated and culturally relevant 
tools to measure breast and cervical cancer symptom awareness in the SSA context. They have 
informed the development and validation of an African Women Awareness of CANcer 
[AWACAN] tool, which can support development and evaluation of interventions relevant to the 
SSA context. 
 
of these cancers.8  This suggests that breast and cervical cancer symptom awareness and 
interpretation can promote timely help-seeking behaviour, diagnosis and start of treatment. 
 
Accurate measurement of cancer symptom awareness, knowledge and beliefs using validated 
tools would enable precise measurement of the impact of cancer awareness interventions. 
Against this background, we conducted a scoping review to identify tools which have been 
utilised to measure breast and cervical cancer symptom awareness in SSA and evidence of 
their validity. Scoping reviews differ from systematic reviews in scope, criteria and quality 
assessment.9-11 Scoping reviews cover a broader scope than systematic reviews which have a 
more clearly defined, narrow scope.  This renders scoping reviews useful when attempting to 
encapsulate and disseminate findings from a diverse body of knowledge. Inclusion and 
exclusion criteria in a scoping study are developed during study selection unlike in a 
systematic review where such criteria are pre-determined prior to study selection, during 
protocol development.  Scoping reviews present evidence based on key themes but do not 
delve in assessment of the quality of such evidence, as is the case in systematic reviews.  
Scoping reviews may be conducted as a preamble - to determine if it is necessary to conduct 
a full systematic review – or as an autonomous exercise, as we did in this review. 
 
Methods 
The review was guided by two questions: (1) Which tools have been used to measure 
symptom awareness in SSA? (2) Have these tools been validated in any SSA populations? 
Following Colquhoun, et al.,12 the review process incorporated the first five stages of Arksey 
and O’Malley’s six-stage framework for conducting scoping reviews9 with Levac, et al. 
enhancements of each stage.10 The five stages are: stage 1: identifying the research question, 
purpose and objectives of the scoping study; stages 2-4: identifying relevant studies, study 
selection and charting the data respectively, and; stage 5: collating, summarising and 
reporting the results.   
 
Identification of relevant studies commenced with a basic search for the terms breast cancer, 
cervical cancer, awareness, beliefs, measures, Africa on Web of Science, Scopus & 
Ebscohost electronic databases.  We then sifted through key studies for potential broader 
search terms, which generated a list of terms (see Appendix 1).  A scoping review of 
literature was then undertaken in PubMed, Web of Science, Ebscohost, Scopus and Cochrane 
databases. This process entailed refining the search strategy with the aim of generating as 
many relevant articles as possible.  The final search strings contained the terms ‘breast; 
cervix*; cancer; neoplasm; symptom*; sign; knowledge; perception*; appraisal; understand*; 
beliefs; attitudes; behavio$r; tool; scale; measure*]’ in various combinations, with the 
Boolean phrases AND/OR.  The database search was supplemented by articles identified by 
searching through reference lists of key articles.   
 
We included peer reviewed journal articles published between January 1997 – February 
2017, written in English and describing primary research in breast and/or cervical cancer 
symptom awareness-related topics in SSA contexts.  Given the focus on tool validation which 
involves evaluating ‘if the measurement tool employed actually measures the intended 
research concept or construct…or if the measurement tools used to quantify the variables 
provide stable or consistent responses’,13 that is, validity and reliability respectively, the 
research team limited articles to quantitative research studies.  The exclusion criteria were: 
articles in languages other than English, non-peer reviewed articles and book chapters, grey 
literature, qualitative studies and studies from low-and-middle-income countries outside SSA.  
Selection of studies involved consultations among the authors who met as a team to establish 
consensus. 
 
Results 
The PRISMA Flow Diagram and checklist14 demonstrates our search strategy and included 
studies.            
   
                FIGURE 1: PRISMA Flow Diagram   
 
Forty-one studies were included.  In these studies, cancer awareness is discussed from 
various perspectives including: symptom knowledge, awareness, perceptions and attitudes 
about breast cancer, cervical cancer or cancer in general, including risk factors.  The studies 
also discussed healthcare use including delays in seeking treatment, pathways to treatment 
and screening practices.  SSA countries featured in this review are Botswana,43 Cameroon,29 
Democratic Republic of Congo, 19 Ghana, 3 Kenya, 20,23,26,52,53 Nigeria, 21,22,24,28,36,38,39,41,47,49 
Sierra Leone, 40 South Africa,18,27,32,46,48,50 Tanzania, 25,30,31,42 Uganda, 15,16,37,45,51 and 
Zimbabwe.44 
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 Additional records identified 
through other sources i.e. project 
database and article reference lists 
(n = 106) 
Records after duplicates removed 
(n = 551) 
Records screened 
(n = 551) 
Records excluded 
(n = 467) 
 
Full-text articles assessed 
for eligibility 
(n = 84) 
Full-text articles excluded (n = 43)  
LMIC but not SSA: 19 
Qualitative studies: 12 
Unable to retrieve articles: 10 
Book chapter/not peer reviewed: 1 
Evaluation of intervention study: 1 
 
Studies included in the 
scoping review  
(n = 41) 
Tools and Validation Processes 
Twenty of the 41 studies used symptom awareness tools but gave no detail on tool validation 
processes3-4, 15-32 (see Table 1, Appendix 2). Twenty-one studies referred to some tool 
validation processes. Of these 19 had limited detail of validation (see Table 2), 33-51 and two 
documented thorough validation processes (see Table 3).52-53  Regarding the 19 studies that 
made some limited reference to validation, two studies noted that they used validated tools 
but did not test the validity of the tools for themselves.33,34 Three studies tested for internal 
reliability35-37: two of which also assessed test-retest reliability with 20 women, 35a,b or an 
unspecified group of women with similar characteristics to the study sample. 36 
14 studies utilised pilot testing38-51 as follows: two studies documented that they pilot tested 
their tools but gave no further information38,39; one study specified that they used pilot testing 
to test reliability of their tool40;  one study alluded to their pilot test serving as a reliability 
(stability) test by identifying their participants as a separate group from that in the actual 
study41; six studies tested content validity using pilot tests followed by modification of items 
based on outcomes of the pilot tests42-47; Four studies utilised piloting for a combination of 
validity and reliability tests48-51.  For instance, use of peer review48 and expert review49 to test 
for content validity, or testing construct validity by structuring content in line with relevant 
subject literature.48 One study provided additional information on the number of items 
discarded and those retained after piloting, with content categories for the latter.49 
  
Table 2: Symptom awareness tools identified; some validation details provided 
 
 
Study Country Focus Design Tool(s) Evidence of validity 
Omotara, B., & 
Yahya, S. (2012)33 
Nigeria BC awareness, attitudes 
and practice 
Cross-sectional 
descriptive 
community-based 
study 
Interviewer 
administered structured 
validated questionnaire 
(23 items) 
States validated questionnaire, but no 
further information provided 
Hyacinth et al 
(2012)34 
Nigeria CC & Pap smear 
awareness & utilisation 
Cross-sectional 
survey 
Validated questionnaire Referenced an unpublished thesis and 
one other study which pre-tested the 
questionnaire with participants 
(n=20) before the final questionnaire 
was developed 
a) Oluwatosin, 
O.A. (200635a); 
b) Oluwatosin, 
O.A. & Oladepo, 
O. (2006)35b 
Nigeria a) Rural women’s 
perceptions of BC & its 
early detection 
measures 
b)  Rural women’s 
perceptions of BC & its 
early detection 
measures 
Cross-sectional 
survey 
Structured 
questionnaire with 4 
questions & 56 items  
Literature, focus groups to refine, test 
/ re-test reliability = 0.95; 
One article specified 20 women 
participated in test/re-test reliability 
 
Oluwatosin, O.A. 
(2010)36 
Nigeria BC: Assessment of risk 
factors & predictive 
factors for breast 
examination 
Cross-sectional 
survey 
Self-developed 3-part 
semi-structured 
questionnaire; one 
section used a validated 
tool [Gail Model]; 
questionnaire tested for 
reliability 
Test/re-test reliability score = 0.95; 
tested with group of women with 
similar characteristics to study 
sample 
 
Twinomujuni, C., 
Nuwaha, F., & 
Babirye, J.N. 
(2015)37 
Uganda Understanding the low 
level of CC screening 
Cross-sectional 
community survey 
Semi-structured 
interviewer 
administered 
questionnaire 
Developed from previously 
published studies & validated tools 
(articles referenced); estimated 
Cronbach’s internal reliability = 0.75 
Akhigbe & 
Omuemo (2009)38 
Nigeria Knowledge, attitudes & 
practice of BC 
screening 
Cross-sectional 
descriptive survey 
Pre-tested self-
administered 
questionnaire 
Pre-test; no further details given on 
pre-test process & function of the 
same 
Kayode, F.O., 
Akande, T.M., & 
Osagbemi, G.K. 
(2005)39 
Nigeria Knowledge, attitude & 
practice of breast self-
examination 
Descriptive cross-
sectional survey 
Pre-tested Structured 
questionnaire 
Pre-tested; no further details given on 
the pre-test process and function of 
the same 
Shepherd, J., & 
Mclnerney, P. 
(2006)40 
Sierra Leone BC knowledge Quantitative 
descriptive-
exploratory design 
Questionnaire Pilot study to test reliability (n=5); no 
results provided 
Obaji, N.C. et al 
(2013)41 
Nigeria Awareness & practice 
of breast self-
examination 
Cross-sectional 
descriptive study 
Interviewer 
administered 
questionnaire 
Validated and pre-tested with a 
separate sample of women 
Lyimo, F.S. & 
Beran, T.N. 
(2012)42 
Tanzania CC Screening: 
Demographic, 
knowledge, attitudinal, 
& accessibility factors 
Cross-sectional 
survey 
Structured 
questionnaire 
Pilot testing in similar context, 
identification & modification of 
problematic questions 
Mingo, A.M. 
(2012)43 
Botswana CC: Awareness & 
Screening 
Hospital-based 
survey 
Questionnaire Content validity [n=3] & revised 
questionnaire accordingly 
Mupepi, S.C. et al 
(2011)44 
Zimbabwe Knowledge, attitudes 
and demographic 
factors influencing CC 
screening behaviour 
Cross-sectional 
community survey 
Questionnaire 6 focus groups of 8 participants each 
[n=48] to test content and construct 
validity 
Kiguli-Malwadde 
at al (2010)45 
Uganda Knowledge, attitude & 
practice of women on 
BC & mammography 
Cross-sectional 
descriptive survey 
Interviewer-
administered 
questionnaire 
Content validity - questionnaire 
reviewed for information quality and 
legitimacy & relevant corrections 
made  
Mugivhi, N.H., 
Maree, J.E. & 
Wright, S.C.D. 
(2009)46 
South Africa Rural women’s 
knowledge of 
prevention & care 
related to BC 
Quantitative 
survey 
Structured interview Pre-tested for validity & reliability 
[n=10] & relevant modifications 
made to questionnaire 
Salaudeen, A.G., 
Akande, T.M., & 
Musa, O.I. 
(2009)47 
Nigeria Knowledge & attitudes 
towards BC & breast 
self-examination 
Cross-sectional 
descriptive survey 
Self-administered 
questionnaire 
Pre-tested [n=30] & revisions made 
accordingly 
Ramathuba, 
Ratshirumbi,Mash
amba, T. M. 
(2015)48 
South Africa BC knowledge, 
attitudes & screening 
practices 
Quantitative 
descriptive cross-
sectional design 
Close-ended 
questionnaire pretested 
for validity and 
consistency 
Content (literature & peer review) & 
construct validity; pre-test reliability 
[n=15] 
Okobia, M.N. et al 
(2006)49 
Nigeria BC: Knowledge, 
attitude and practice  
Cross-sectional 
community survey 
Interviewer 
administered 
questionnaire 
Content validity (literature & expert 
review) pre-tested for reliability 
[n=25] & ambiguous questions 
discarded 
Francis, S.A. et al 
(2010)50 
South Africa Attitudes & knowledge 
about HPV & CC risk 
Brief survey Questionnaire Developed based on literature review 
(articles referenced), pilot-tested & 
revised with a clinic-based 
population similar to the clinic 
sample 
Mwaka, A.D. et 
al. (2015)51 
Uganda Community awareness 
of CC risk factors and 
symptoms 
Cross-sectional 
population-based 
survey 
Structured 
questionnaire  
Developed based on literature review 
(articles referenced) & pilot test 
Table 3 shows the two articles which gave a detailed account of their validation 
processes52,53.  Both articles reported a study conducted by a research team from the 
Academic Model Providing Access to Healthcare [AMPATH] Oncology Institute, based in 
Eldoret, Kenya.  One explored lay perceptions of breast cancer52, while the other sought to 
establish the validity and reliability of the UK Breast Cancer Awareness Measure (BCAM)55 
in a Kenyan context.53   
 
Table 3: Symptom awareness tools identified; thorough validation 
 
Naanyu, et al.,52 modified BCAM items by adding open-format questions relating to 
symptoms, severity and treatment of breast cancer, to suit their Kenyan audience.  The 
specific questions were not detailed in the article.  Further, two open-ended questions were 
added to the tool as follows: (1) “What are some beliefs, opinions and traditions that you 
have heard from others about breast cancer?” (2) “In your opinion, what are some of the early 
warning signs of breast cancer, the ways in which one may know first that s/he has this 
condition?” (p. 149)  The questionnaire was translated into Kiswahili, Kenya’s national 
language, and this version subjected to content validation via three focus group discussions 
consisting of men and women without cancer aged 18 years and above, attending non-cancer 
outpatient clinics.    
 
Wachira, et al.,53 focused on validation of the BCAM in a Kenyan setting, based their work 
on 1061 women and an additional 48 women who participated in six cognitive focus group 
discussions.  The authors opted to use BCAM in the absence of locally validated tools 
applicable in the Kenyan context. Of specific interest to this research team were two BCAM 
domains, breast awareness and perceived barriers to screening, which the Kenyan researchers 
associated with delays in timely interventions to enhance early breast cancer detection.  
Cognitive focus group interviews revealed that compound questions in the BCAM knowledge 
domain [for example, “do you think discharge or bleeding [italics added] from your nipple 
could be a sign of breast cancer?”] were confusing to participants, who recommended that 
Study Country Focus Design Tool(s) 
Naanyu, V., 
et al., 
(2015)52 
Kenya Lay perceptions of BC in 
Western Kenya 
Cross-sectional survey BCAM adapted: opinions about causes, 
symptoms, severity and treatment of BC 
captured as free-text responses to open-
ended questions added to the BCAM 
tool. 
Wachira, J., 
et al., 
(2017)53 
Kenya Psychometric assessment 
of BCAM for assessment 
of BC knowledge and 
barriers to screening in 
Kenya 
Cross-sectional survey BCAM: Assessment of face and 
psychometric validity of BCAM using 
cognitive testing (and adaptation of 
some items), factor analysis of survey 
data and correlations 
these questions be rephrased for clarity.  The study observed variances in cultural 
interpretation of some items as well as nuances around translation of BCAM items into 
Kiswahili.  For example, participants requested for clarification on the BCAM question “do 
you think that redness of your breast skin could be a sign of breast cancer”, noting that unless 
the top surface of the skin peels off, dark skin would not usually turn red.  This resulted in 
rephrasing of the question to read “change in skin colour” in lieu of redness for contextual 
relevance.   
 
Discussion 
Our scoping review provides a synthesis of research12 on tools used to measure symptom 
awareness in SSA and determining if such tools have been validated in SSA settings.  In this 
regard, our review identified gaps in SSA breast and cervical cancer tool validation literature 
by presenting the extent of research and how this research was conducted11 in the period 
between 1997 and 2017. Scoping reviews are useful in various research aspects, including: 
examining the extent, range and nature of research activity; establishing the relevance of 
conducting a full systematic review; succinctly presenting and circulating research results, 
and; identifying gaps in literature.9 In addressing how the research was conducted, the 
scoping review was limited to a narrative descriptive account of studies included and not a 
detailed analysis of the quality of these studies, which would be possible in a systematic 
review.9 
 
Our findings demonstrate that several tools have been utilised to measure breast and cervical 
cancer in SSA contexts.  Of the 41 SSA studies reviewed, 20 studies utilised tools that were 
not validated.15-32  The other 21 studies identified tools used and offered information of 
varying detail regarding validation processes.33-53 with only two studies demonstrating 
detailed and systematic tool validation processes.52,53 Even so, these two studies are limited in 
that they show evidence of thorough validation focused on (a) breast cancer but not cervical 
cancer (b) only two of the BCAM domains namely, knowledge and/or perceptions of breast 
cancer and barriers to screening.   
 
Twenty of the 41 studies reviewed were on breast cancer.  Of these 20, 6 utilised tools that 
were not validated 3,4,17,22,24,28 while 14 used validated tools,33,35,36,38-41,45-49,52,53 including the 
two that furnished detailed accounts of their validation process.52,53 Eighteen of the 41 studies 
reviewed focused on cervical cancer themes.  Of these 18, 11 studies utilised tools that were 
not validated15,16,18-21,23,25,26,29,31, while 7 utilised validated tools.34,37,42-44,50,51 Overall, more 
breast cancer studies (14) utilised validated tools than cervical cancer studies (7), most of 
which (11) utilised tools that were not validated.  Of the 41 studies, 1 combined breast and 
cervical cancer themes32 while 2 studies investigated cancer symptom awareness in general 
but also made mention of breast and cervical cancer symptom awareness among women in 
SSA.27,30 All 3 studies used tools that were not validated.   
 
Our results point to the dearth of comprehensively validated and culturally relevant tools to 
measure breast and cervical cancer symptom awareness in the SSA context, and the need for 
systematic efforts to develop and validate such tools. These findings are consistent with a 
study on understanding low cervical cancer screening in Uganda, which noted lack of 
validated tools in African settings.37 Using consistent and reliable measures in cancer studies 
contributes to the quality of research results54 which, in turn, will inform oncology practice in 
far as ‘standardised, valid measurement is essential for monitoring levels of cancer 
awareness, examining its risk factors and consequences, and evaluating interventions to 
promote it’.55 
 
Further, validated tools should be culturally relevant for their intended study 
populations.52,53,56 The Cancer Awareness Measure (CAM) and the Awareness and Beliefs 
about Cancer (ABC) tool were developed in the UK to assess cancer awareness in the public; 
they include generic cancer awareness and cancer specific measures for breast cancer 
(BCAM) and cervical cancer (CCAM).57 These tools could be of value in SSA; however, as 
they were developed in a very different sociocultural setting, they are likely to need 
adaptation for use in SSA. In our specific study context, validated tools which are culturally 
relevant in SSA settings will serve as standardised comparative measures to (a) assess breast 
and cervical cancer awareness, knowledge and beliefs, and (b) enable precise appraisal of 
breast and cervical cancer awareness interventions.  Our findings have informed the 
development of an African Women Awareness of CANcer [AWACAN] tool to measure 
breast and cervical cancer awareness. 
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Appendix 1 
 
List of Potential Search Terms from Existing Literature  
 
  
 
 
1.      Breast cancer 
2.      Cervical cancer 
3.      Symptom* 
4.      Signs 
5.      Symptom appraisal 
6.      Symptom interpretation 
7.      Beliefs 
8.      Attitudes 
9.      Expressions 
10.  Communication 
11.  Conceptualization 
12.  Lay perceptions 
 13.  Behaviour 
14.  Knowledge  
15.  Literacy 
16.  Ignorance 
17.  Culture 
18.  Stigma 
19.  Abscond 
20.  Awareness 
21.  Understanding 
22.  Construct* 
23.  Expectations 
24.  Challenges 
25.  Opportunities 
26.  Tools 
27.  Scales 
28.  Patterns 
29.  Measures 
30.  Questions 
31.  Validation 
32.  Management 
33.  Disclosure 
34.  Report 
35.  Risk* 
36.  Barriers 
 37.  Facilitators 
38.  Screening 
39.  Delayed      
diagnosis 
40.  Timely diagnosis 
41.  Treatment 
42.  Cancer control 
43.  Cancer 
management 
44.  Qualitative 
45.  Quantitative 
46.  Africa 
47.  Sub-Saharan 
Africa OR Africa 
South of the Sahara 
48.  Low resource 
countries 
 49. Rural 
50. Urban 
Appendix 2 
Table 1: Symptom awareness tools identified; no validation details provided 
 
 
  
Study Country Focus Design Tool(s) Validated 
Mukama, T., 
et al (2017)15 
 Uganda Knowledge and attitudes toward cervical 
cancer [CC] prevention 
community-based 
cross-sectional survey 
Questionnaire  No 
Ndejjio, R, et 
al (2016)16 
Uganda Uptake of CC screening & associated 
factors 
cross-sectional 
descriptive survey 
Semi-structured questionnaire No 
Azubuike, S. 
O., & 
Unuoha, C. 
O. (2015)17 
Nigeria 
 
Breast cancer [BC] awareness, risk 
factors, signs & symptoms, preventive 
measures, attitudes, cure prevention, 
causes, practices, and associated factors 
cross-sectional 
community survey 
Semi-structured questionnaire 
developed from previous 
published studies [studies not 
cited] 
No 
Dreyer, et al. 
(2015)18 
South 
Africa 
School based HPV vaccination & CC 
knowledge 
cross-sectional school-
based study 
Interviewer-administered 
structured questionnaire 
No 
Ali-Risasi et 
al (2014)18 
DRC Knowledge, attitude & practice about 
cancer of the uterine cervix 
cross-sectional survey Interviewer-administered 
questionnaire 
No 
Morema, 
E.N. et al 
(2014)20 
Kenya Determinants of CC screening services 
uptake 
cross-sectional survey Self-administered structured 
questionnaires 
No 
Ahmed, S.A. 
et al (2013)21  
Nigeria Knowledge, attitude & practice of CC 
screening 
cross-sectional 
descriptive survey 
Questionnaire (closed & open-
ended questions) 
No 
Azubuike, S. 
& Okwuokei, 
S. (2013)22 
Nigeria Level of BC awareness, attitudes and 
practices towards early detection 
strategies 
cross-sectional 
descriptive survey 
Self-administered semi-
structured questionnaire with 
23 items developed from 
previous published studies 
[studies not cited] 
No 
Sudenga, 
S.L. et al 
(2013)23 
Kenya CC: Knowledge, attitudes, practices & 
perceived risk 
cross-sectional survey Interviewer-administered 
questionnaire 
No 
Irurhe, N.K. 
et al (2012)24 
Nigeria Knowledge & awareness of BC cross-sectional survey Self-administered 
questionnaire 
No 
Kahesa,C. et 
al (2012)25 
Tanzania Determinants of acceptance of CC 
screening 
cross-sectional survey Structured questionnaire No 
Were, E.N., 
Nyaberi, Z. 
& Buziba, N. 
(2011)26 
Kenya CC screening: Perceptions of risk & 
barriers 
cross-sectional survey Semi-structured questionnaire No 
Maree, J. E., 
& Wright, S. 
C. (2010)27 
South 
Africa 
Cancer understanding, awareness, and 
health seeking behaviours 
exploratory, contextual, 
quantitative door-to-
door survey 
Structured questionnaire  No 
Clegg-
Lamptey, J., 
Dakubo, J., 
& Attobra, 
Y. N. (2009)3 
Ghana BC- late presentation and treatment 
absconding  
cross-sectional survey Interviewer-administered 
questionnaire 
No 
Osime, O.C. 
et al. (2008)28 
Nigeria BC knowledge, attitudes and practice cross-sectional survey structured self-administered 
questionnaire 
No 
Tebeu, P.M. 
et al (2008)29 
Cameroon CC: attitude & Knowledge hospital-based survey Questionnaire No 
Ukwenya, A. 
Y. et al. 
(2008)4 
Nigeria Delayed treatment of symptomatic BC cross-sectional study 
 
Structured open-ended 
questionnaire 
No 
Kazaura, 
M.R. et al 
(2007)30 
Tanzania Health seeking behaviour among CA 
patients 
hospital-based survey Structured and semi-structured 
interviews 
No 
Kidanto, 
H.L., 
Kilewo, 
C.D., & 
Moshiro,C. 
(2002)31 
Tanzania CC: Knowledge and attitudes of female 
patients 
comparative cross-
sectional survey 
Structured questionnaire No 
Pillay, A. L. 
(2002)32 
South 
Africa 
BC & CC Awareness  community based 
survey 
Interviewer-administered 
structured questionnaire (fixed 
format) – sample questions 
included; informed by 
oncology literature [not 
specified] 
No 
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